Formation of a highly peptide-receptive state of class II MHC

Immunity

Volumn 9, Issue 5, 1998, Pages 699-709

  Rabinowitz, Joshua D ^a   Vrljic, Marija ^a   Kasson, Peter M ^a   Liang, Michael N ^a   Busch, Robert ^a   Boniface, J Jay ^a   Davis, Mark M ^a   McConnell, Harden M ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE;

ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; DISSOCIATION; ISOMERISM; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

EID: 0032212792     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80667-6     Document Type: Article

References (52)

1. Baker, D., and Agard, D.A. (1994). Kinetics versus thermodynamics in protein folding. Biochemistry 33, 7505-7509.
2. Beeson, C., and McConnell, H.M. (1994). Kinetic intermediates in the reactions between peptides and proteins of the class II major histocompatibility complex. Proc. Natl. Acad. Sci. USA 91, 8842-8845.
3. Beeson, C., Rabinowitz, J., Tate, K., Gütgemann, I., Chien, Y.H., Jones, P.P., Davis, M.M., and McConnell, H.M. (1996). Early biochemical signals arise from low-affinity T cell receptor-ligand reactions at the cell-cell interface. J. Exp. Med. 184, 777-782.
4. + T cell selection in mice lacking invariant chain expression. J. Exp. Med. 177, 1699-1712.
5. Boniface, J., Allbritton, N.L., Reay, P.A., Kantor, R.M., Stryer, L., and Davis, M.M. (1993). pH affects both the mechanism and specificity of peptide binding to a class II major histocompatibility complex molecule. Biochemistry 32, 11761-11768.
6. Buus, S., Sette, A., Colon, S.M., Jenis, D.M., and Grey, H.M. (1986). Isolation and characterization of antigen-la complexes involved in T cell recognition. Cell 47, 1071-1077.
7. Buus, S., Sette, A., Colon, S.M., and Grey, H.M. (1988). Autologous peptides constitutively occupy the antigen binding site on la. Science 242, 1045-1047.
8. Chapman, H.A. (1998). Endosomal proteolysis and MHC class II function. Curr. Opin. Immunol. 10, 93-102.
9. Denzin, L.K., and Cresswell, P. (1995). HLA-DM induces CLIP dissociation from MHC class II alpha-beta dimers and facilitates peptide loading. Cell 82, 155-165.
10. Denzin, L.K., Hammond, C., and Cresswell, P. (1996). HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J. Exp. Med. 184, 2153-2165.
11. Feng, M.H., and Lai, M.Z. (1994). A peptide binding weakly to the major histocompatibility molecule augments T cell responses. Eur. J. Immunol. 24, 355-361.
12. Fersht, A. (1985). Enzyme structure and mechanism. (New York: W.H. Freeman and Co.), pp. 89-90.
13. Fremont, D.H., Hendrickson, W.A., Marrack, P., and Kappler, J. (1996). Structures of an MHC class II molecule with covalently bound single peptides. Science 272, 1001-1004.
14. Germain, R.N., and Rinker, A.G. (1993). Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes surface expression of occupied molecules. Nature 363, 725-728.
15. Ghosh, P., Amaya, M., Mellins, E., and Wiley, D.C. (1995). The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 378, 457-462.
16. Goldberg, J.M., and Baldwin, R.L. (1998). Kinetic mechanism of a partial folding reaction: 1. properties of the reaction and effects of denaturants. Biochemistry 37, 2546-2555.
17. Harrison, P., Bamborough, P., Daggett, V., Prusiner, S.B., and Cohen, F.E. (1997). The prion folding problem. Curr. Opin. Struct. Biol. 7, 53-59.
18. Jensen, P.E. (1990). Regulation of antigen presentation by acidic pH. J. Exp. Med. 171, 1779-1784.
19. Jensen, P.E. (1991). Enhanced binding of peptide antigen to purified class II major histocompatibility glycoproteins at acidic pH. J. Exp. Med. 174, 1111-1120.
20. Karlson, L., Peleraux, A., Lindstedt, R., Liljedahl, M., and Peterson, P.A. (1994). Reconstitution of an operational MHC class II compartment in non-antigen-presenting cells. Science 266, 1569-1573.
21. Kropshofer, H., Arndt, S.O., Moldenhauer, G., Hammerling, G.J., and Vogt, A.B. (1997). HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH. Immunity 6, 293-302.
22. Lee, C., and McConnell, H.M. (1995). A general model of invariant chain association with class II major histocompatibility complex proteins. Proc. Natl. Acad. Sci. USA 92, 8269-8273.
23. Liang, M.N., Beeson, C., Mason, K., and McConnell, H.M. (1995). Kinetics of the reactions between the invariant chain (85-99) peptide and proteins of the murine class II MHC. Int. Immunol. 7, 1397-1404.
24. McConnell, H.M., Wada, H.G., Arimilli, S., Fok, K.S., and Nag, B. (1995). Stimulation of T cell by antigen-presenting cells is kinetically controlled by antigenic peptide binding to major histocompatibility complex class II molecules. Proc. Natl. Acad. Sci. USA 92, 2750-2754.
25. Morris, P., Shaman, J., Attaya, M., Amaya, M., Goodman, S., Bergman, C., Monaco, J.J., and Mellins, E. (1994). An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature 368, 551-554.
26. Pieters, J. (1997). MHC class II restricted antigen presentation. Curr. Opin. Immunol. 9, 89-96.
27. Pinet, V., Vergelli, M., Martin, R., Bakke, O., and Long, E.O. (1995). Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature 375, 603-606.
28. Rabinowitz, J.D., Beeson, C., Wulfing, C., Tate, K., Allen, P.M., Davis, M.M., and McConnell, H.M. (1996). Altered T cell receptor ligands trigger a subset of early T cell signals. Immunity 5, 125-135.
29. Rabinowitz, J.D., Liang, M.N., Tate, K., Lee, C., Beeson, C., and McConnell, H.M. (1997). Specific T cell recognition of kinetic isomers in the binding of peptide to class II MHC. Proc. Natl. Acad. Sci. USA 94, 8702-8707.
30. Reay, P.A., Wettstein, D.A., and Davis, M.M. (1992). pH dependence and exchange of high and low responder peptides binding to a class II MHC molecule. EMBO J. 11, 2829-2839.
31. Reay, P.A., Kantor, R.M., and Davis, M.M. (1994). Use of global amino acid replacements to define the requirements for MHC binding and T cell recognition of moth cytochrome c (93-103). J. Immunol. 752, 3946-3957.
32. Reich, Z., Altman, J.D., Boniface, J.J., Lyons, D.S., Kozono, H., Ogg, G., Morgan, C., and Davis, M.M. (1997). Stability of empty and peptide-loaded class II major histocompatibility complex molecules at neutral and endosomal pH: comparsion to class I proteins. Proc. Natl. Acad. Sci. USA 94, 2495-2500.
33. Roche, P.A., and Cresswell, P. (1990). High-affinity binding of an influenza hemagglutinin-derived peptideto purified HLA-DR. J. Immunol. 144, 1849-1856.
34. Roof, R.W., Luescher, I.F., and Unanue, E.R. (1990). Phospholipids enhance the binding of peptides to class II major histocompatibility molecules. Proc. Natl. Acad. Sci. USA 87, 1735-1739.
35. k. Nature 337, 274-276.
36. Sadegh-Nasseri, S., Stern, L.J., Wiley, D.C., and Germain, R.N. (1994). MHC class II function preserved by low-affinity peptide-interactions preceding stable binding. Nature 370, 647-650.
37. Schwartz, R.H., Fox, B.S., Fraga, E., Chen, C., and Singh, B. (1985). The T lymphocyte response to cytochrome c: V. determination of the minimal peptide seize required for stimulation of T cell clones and assessment of the contribution of each residue beyond this size to antigenic potency. J. Immunol. 735, 2598-2608.
38. Sette, A., Southwood, S., O'Sullivan, D., Gaeta, F.C.A., Sidney, J., and Grey, H.M. (1992). Effect of pH on MHC class II-peptide interactions. J. Immunol. 148, 844-851.
39. Sette, A., Southwood, S., Miller, J., and Appella, E. (1995). Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II. J. Exp. Med. 181, 677-683.
40. Sherman, M.A., Weber, D.A., and Jensen, P.E. (1995). DM enhances peptide binding to class II MHC by release of invariant chain-derived peptides. Immunity 3, 197-205.
41. Sloan, V.S., Cameron, P., Porter, G., Gammon, M., Amaya, M., Mellins, E., and Zaller, D.M. (1995). Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375, 802-806.
42. Springer, S., Doring, K., Skipper, J.C.A., Townsend, A.R.M., and Cerundolo, V. (1998). Fast association rates suggest a conformational change in the MHC class I molecule H-2Db upon peptide binding. Biochemistry 37, 3001-3012.
43. Stern, L.J., and Wiley, D.C. (1992). The human class II MHC protein HLA-DR1 assembles as empty α-β heterodimers in the absence of antigenic peptide. Cell 68, 465-477.
44. Stern, L.J., Brown, J.H., Jardetzky, T.S., Gorga, J.C., Urban, R.G., Strominger, J.L, and Wiley, D.C. (1994). Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368, 215-221.
45. Tampe, R., and McConnell, H.M. (1991). Kinetics of antigenic peptide binding to the class II major histocompatibility molecule I-Ad. Proc. Natl. Acad. Sci. USA 88, 4661-4665.
46. Tompkins, S.M., Moore, J.C., and Jensen, P.E. (1996). An insulin peptide that binds an alternative site in class II major histocompatibility complex. J. Exp. Med. 183, 857-866.
47. Viville, S., Neefjes, J., Lotteau, V., Dierich, A., Lemeur, M., Ploegh, H., Benoist, C., and Mathis, D. (1993). Mice lacking the MHC class II-associated invariant chain. Cell 72, 635-648.
48. Wang, Z., Mottonen, J., and Goldsmith, E.J. (1996). Kinetically controlled folding of the serpin plasminogen activator inhibitor 1. Biochemistry 35, 16443-16448.
49. Wettstein, D.A., Boniface, J.J., Reay, P.A., Schild, H., and Davis, M.M. (1991). Expression of a class II major histocompatibility complex (MHC) heterodimer in a lipid-linked form with enhanced peptide/soluble MHC complex formation at low pH. J. Exp. Med. 174, 219-228.
50. Witt, S.N., and McConnell, H.M. (1993). The kinetics of peptide reactions with class II major histocompatibility complex membrane proteins. Acc. Chem. Res. 26, 442-448.
51. Witt, S.N., and McConnell, H.M. (1994). Formation and dissociation of short-lived class II MHC-peptide complexes. Biochemistry 33, 1861-1868.
52. Zhong, G., Romagnoli, P., and Germain, R.N. (1997). Related leucine-based cytoplasmic targeting signals in invariant chain and major histocompatibility complex class-II molecules control endocytic presentation of distinct determinants in a single protein. J. Exp. Med. 185, 429-438.